Cargando…
A BAP1 Mutation-specific MicroRNA Signature Predicts Clinical Outcomes in Clear Cell Renal Cell Carcinoma Patients with Wild-type BAP1
Background: Clear cell renal cell carcinoma (ccRCC) is the most prevalent histologic subtype of kidney cancers in adults, which could be divided into two distinct subgroups according to the BRCA1 associated protein-1 (BAP1) mutation status. In the current study, we comprehensively analyzed the genom...
Autores principales: | Ge, Yu-Zheng, Xu, Lu-Wei, Zhou, Chang-Cheng, Lu, Tian-Ze, Yao, Wen-Tao, Wu, Ran, Zhao, You-Cai, Xu, Xiao, Hu, Zhi-Kai, Wang, Min, Yang, Xiao-Bing, Zhou, Liu-Hua, Zhong, Bing, Xu, Zheng, Li, Wen-Cheng, Zhu, Jia-Geng, Jia, Rui-Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595094/ https://www.ncbi.nlm.nih.gov/pubmed/28900502 http://dx.doi.org/10.7150/jca.20234 |
Ejemplares similares
-
To BaP or not to BaP? That is the question.
por: Goldstein, L S
Publicado: (2001) -
BAP31 regulates IRAK1-dependent neuroinflammation in microglia
por: Liu, Xia, et al.
Publicado: (2019) -
MBD5 and MBD6 stabilize the BAP1 complex and promote BAP1-dependent cancer
por: Tsuboyama, Natsumi, et al.
Publicado: (2022) -
BAP1 Tumour Predisposition Syndrome Due to Whole BAP1 Gene Deletion
por: Pandithan, Dinusha, et al.
Publicado: (2022) -
BAP1-defficient breast cancer in a patient with BAP1 cancer syndrome
por: Blatnik, Ana, et al.
Publicado: (2022)